glp1.how

advocacy

What a successful insurance appeal campaign looks like

A well-run appeal isn't just a form — it's a small campaign with documentation, timing, and escalation built in. Here's what separates appeals that succeed from ones that stall.

Updated Jul 14, 2026

Why "appeal" undersells what actually works

A denial letter can feel final, but insurance appeals have a structured, multi-stage process — and patients who treat it as a deliberate campaign, rather than a single form submission, are more likely to succeed. This guide walks through what a well-run appeal typically includes, building on our FAQ My insurance denied coverage. What now?

The typical stages

  1. Understand the specific denial reason. Denials cite a specific code or explanation (e.g., "not medically necessary," "step therapy not completed," "excluded benefit"). The appeal has to directly address that specific reason — a generic appeal letter that doesn't engage with the stated denial reason is far less likely to succeed.
  2. Internal appeal (first level). Your prescriber submits additional documentation — clinical notes, BMI and comorbidity history, prior treatment attempts — directly addressing the denial reason. This is where most successful appeals are resolved.
  3. Internal appeal (second level, if applicable). Some plans have a second internal review tier, sometimes involving a different reviewer or medical director, before external review becomes available.
  4. External review. If internal appeals fail, most plans are required to offer an independent external review by a third party not affiliated with the insurer — this is a meaningful, often underused, escalation step. See our guide on escalation paths beyond your insurer for how this and other outside options work.

What tends to separate successful appeals from unsuccessful ones

  • Directly rebutting the stated denial reason, point by point, rather than restating general medical need
  • Including specific clinical documentation — lab values, BMI history, comorbidity diagnoses, prior treatment attempts — rather than a general letter of support
  • Meeting deadlines precisely. Appeals have strict submission windows; missing one can forfeit the right to escalate further.
  • Persistence across levels. Many successful outcomes happen at the second internal review or external review stage, not the first — treating an initial denial as the final word, rather than stage one of a process, is the most common reason people give up too early.
  • A prescriber's office experienced with the process. Practices that handle GLP-1 prior authorizations and appeals regularly often know exactly what documentation a specific insurer or PBM responds to.

The bottom line

A denial is frequently the start of a process, not the end of one. Appeals that succeed tend to be specific, well-documented, and pursued through each available level rather than stopping after the first attempt.